Stem-like PD-1 <sup>+</sup> TCF-1 <sup>+</sup> CD8 <sup>+</sup> T cells result from helpless priming and rely on CD4 <sup>+</sup> T-cell help to complete their cytotoxic effector differentiation

BACKGROUND: differentiation state that progresses into terminal exhaustion in cancer and chronic infection. These stem-like cells are important, since they are the responders to PD-1 targeted immunotherapy and a potential resource for antitumor immunity. METHODS: T-cell help in the immunogenic MC38 tumor model. RESULTS: T cells into helped cytotoxic effectors. CONCLUSIONS: T cells to drive their expansion and differentiation into cytotoxic effectors is therefore an important therapeutic challenge in cancer and other conditions that lead to T-cell exhaustion.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2026-04-01
DOI
https://doi.org/10.1136/jitc-2025-014041
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stem-like PD-1 + TCF-1 + CD8 + T cells result from helpless priming and rely on CD4 + T-cell help to complete their cytotoxic effector differentiation

Jannie Borst, Julia Busselaar, Xin Lei, Mo D. Staal et al.
Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and Biomarkers
article

Stem-like PD-1 + TCF-1 + CD8 + T cells result from helpless priming and rely on CD4 + T-cell help to complete their cytotoxic effector differentiation

Jannie Borst, Julia Busselaar, Xin Lei, Mo D. Staal, Yanling Xiao, Douwe M T Bosma
article en

Abstract

BACKGROUND: differentiation state that progresses into terminal exhaustion in cancer and chronic infection. These stem-like cells are important, since they are the responders to PD-1 targeted immunotherapy and a potential resource for antitumor immunity. METHODS: T-cell help in the immunogenic MC38 tumor model. RESULTS: T cells into helped cytotoxic effectors. CONCLUSIONS: T cells to drive their expansion and differentiation into cytotoxic effectors is therefore an important therapeutic challenge in cancer and other conditions that lead to T-cell exhaustion.

Journal for ImmunoTherapy of CancerVol. 14(4)
Leiden University Medical Center (NL), Oncode Institute (NL)
KWF Kankerbestrijding, Oncode Institute
Openalex Percentile: Top 20%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Stem-like PD-1 <sup>+</sup> TCF-1 <sup>+</sup> CD8 <sup>+</sup> T cells result from helpless priming and rely on CD4 <sup>+</sup> T-cell help to complete their cytotoxic effector differentiation — Jannie Borst, Julia Busselaar, et al. · Journal for ImmunoTherapy of Cancer (2026) | TGRS Research Map | TGRS